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The membrane fluidity of antigen-presenting cells (APCs) has a significant bearing on T-cell-stimulating
ability and is dependent on the cholesterol content of the membrane. The relationship, if any, between
membrane fluidity and defective cell-mediated immunity in visceral leishmaniasis has been investigated.
Systemic administration of cholesterol by liposome delivery (cholesterol liposomes) in Leishmania donovani-
infected hamsters was found to cure the infection. Splenic macrophages as a prototype of APCs in infected
hamsters had decreased membrane cholesterol and an inability to drive T cells, which was corrected by
cholesterol liposome treatment. The effect was cholesterol specific because liposomes made up of the analogue
4-cholesten-3-one provided almost no protection. Infection led to increases in interleukin-10 (IL-10), trans-
forming growth factor beta, and IL-4 signals and concomitant decreases in gamma interferon (IFN-), tumor
necrosis factor alpha, and inducible NO synthase signals, which reverted upon cholesterol liposome treatment.
The antileishmanial T-cell repertoire, whose expansion appeared to be associated with protection, was pre-
sumably type Th1, as shown by enhanced IFN- signals and the predominance of the immunoglobulin G2
isotype. The protected group produced significantly more reactive oxygen species and NO than the infected
groups, which culminated in killing of L. donovani parasites. Therefore, cholesterol liposome treatment may be
yet another simple strategy to enhance the cell-mediated immune response to L. donovani infection. To our
knowledge, this is the first report on the therapeutic effect of cholesterol liposomes in any form of the disease.
The disease visceral leishmaniasis or kala-azar is spreading
in the Indian subcontinent and elsewhere, and evolution of
antimony-resistant strains has been compounding this disaster
(14). The inability of kala azar patients to mount an antileish-
manial cell-mediated immune response is the hallmark of the
disease (28). So far, there is no effective vaccine against kala-
azar. Among the drugs used, pentamidine is toxic, amphoter-
icin B is expensive for the target population on the subconti-
nent and toxic (and there have been reported cases of
resistance) (67), and use of oral miltefosine is limited by cost,
contraindications, and the emergence of resistance (69). In
view of these limitations there is an urgent need to develop an
affordable therapy. The work presented here is directed toward
this goal. The idea that cholesterol-rich liposomes may have a
therapeutic role in treatment of leishmaniasis stems from our
previous finding that during their intracellular life cycle Leish-
mania parasites disrupt the membrane rafts of macrophages
(Ms) by increasing membrane fluidity. The increase in fluid-
ity, when corrected physically by exposing the parasitized Ms
to a temperature lower than the phase transition temperature
or chemically by liposomal delivery of cholesterol, leads to
correction of antigen presentation (10). This encouraging re-
sult, coupled with the fact that cholesterol has been identified
as a potential therapeutic agent for use against leishmania
infection (50), brought into focus the therapeutic efficacy of
cholesterol-rich liposomes in Leishmania donovani-infected
hamsters. Cholesterol therapy is in clinical use either directly
or as an adjunct to treatment. Compared to drug treatment
alone, a cholesterol-rich diet together with an antitubercular
drug increased the rate of sterilization of sputum in patients
having pulmonary tuberculosis (48). Patients with Smith-
Lemli-Opitz syndrome who were treated with a pure choles-
terol suspension orally showed improvement in symptoms
associated with the disease (16).
The role of membrane cholesterol in the T-cell—antigen-pre-
senting cell (APC) interaction has been well studied in various
systems. Cholesterol depletion results in inhibition of phytohem-
agglutinin-dependent lymphocyte cytotoxicity against allogeneic
target cells, and the opposite effect is observed after cholesterol
enrichment (15). Cholesterol treatment enhances the antigen-
presenting function of monocytes by upregulating the expression
of major histocompatibility complex (MHC) class II (25), pro-
motes phagocytosis of Helicobacter pylori by APCs, and enhances
an antigen-specific T-cell response during bacterial challenge,
leading to a T-cell-dependent reduction in the number of bacteria
in the stomach (68). Treatment of APCs with nystatin or methyl
cyclodextrin, which are known quenchers of cholesterol from the
membrane, reduces the antigen-presenting ability without affect-
ing the cell surface expression of class II molecules (4). Thus,
cholesterol may play a decisive role in the cell-mediated immune
response of the host. Membrane cholesterol regulates membrane-
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embedded receptors in terms of their affinity state, binding ca-
pacity, and signal transduction (9). Cholesterol is necessary for
raft assembly (59), which is intimately involved in the dynamics of
immune synapse formation, an essential event in T-cell receptor-
mediated signal transduction (52). Recently, it was shown that the
level of serum cholesterol decreased during the active stage of
kala azar but that the levels of all the lipid parameters returned to
the normal reference ranges after successful chemotherapy (33).
As a part of our continuing search for new horizons for kala
azar therapy, we studied the therapeutic role, if any, of lipo-
somal delivery of cholesterol in L. donovani-infected hamsters
(I-hamsters). This was expected to allow us to examine a num-
ber of cholesterol-induced cellular phenomena associated with
the antileishmanial immune response and protection.
MATERIALS AND METHODS
Antibodies and other reagents. Biotin-conjugated mouse anti-Armenian and
anti-Syrian hamster immunoglobulin G1 (IgG1) monoclonal antibody (MAb) and
avidin-horseradish peroxidase-conjugated mouse anti-Syrian hamster IgG2 MAb
were obtained from BD Biosciences. Penicillin, streptomycin, sodium bicarbonate,
HEPES, 2-mercaptoethanol, fura-2-acetoxymethyl ester, paraformaldehyde, fluores-
cein isothiocyanate (FITC)-conjugated cholera toxin B subunit (CTXB-FITC), 2,2-
azinobis(3-ethylbenzthiazoline-6-sulfonate) (ABTS), a PKH26 cell-labeling kit,
sulfanilamide, N-(1-naphthyl)ethylene diamine hydrochloride, Giemsa stain, Brad-
ford’s reagent, EDTA, and RPMI 1640 were purchased from Sigma Aldrich (St.
Louis, MO). Phosphatidylcholine (PC) (egg lecithin) and 4-cholesten-3-one were
purchased from ICN (Irvine, CA). Anti-kinetoplastid membrane protein 11 (KMP-
11) MAb (mouse IgG1) was obtained from Cedarlane Lab (Ontario, Canada).
FITC-conjugated anti-mouse IgG was obtained from Jackson Laboratories, United
States. Cholesterol, hydrogen peroxide, and Tween 20 were obtained from Merck.
[3H]thymidine (specific activity, 6.7 Ci/mmol) was purchased from New England
Nuclear, Boston, MA. 2,7-Dichlorodihydrofluorescein diacetate was obtained from
Molecular Probes (Eugene, OR). Preservative-free sodium antimony gluconate
(SAG) was a kind gift from Albert David Ltd. (Kolkata, India).
Propagation of parasite, infection of hamsters, determination of the parasite
burden, and preparation of SLA. Golden hamsters (4 to 6 weeks old) were
obtained from the animal facility of the Indian Institute of Chemical Biology.
They were housed under conventional conditions with food and water provided
ad libitum, and they were used for experiments with prior approval of the
institutional animal ethics committee. L. donovani strain AG83 (MAOM/IN/
1083/AG83), originally obtained from an Indian kala-azar patient, was used to
infect 4- to 6-week-old hamsters with either amastigotes or promastigotes (5 
106 parasites/animal) by the intracardiac route (44). Splenic and hepatic parasite
burdens in hamsters were determined by the stamp smear method as described
previously (61); the results are expressed as numbers of parasites per spleen and
numbers of parasites per liver, respectively. Soluble leishmanial antigen (SLA)
was prepared after sonication of promastigotes as described previously (57).
Liposome preparation, visualization by TEM, measurement of size, systemic
delivery of liposomes, and injection of sub-SAG. Liposomes were prepared from
PC and either cholesterol or an analogue of cholesterol (4-cholesten-3-one) at a
molar ratio of 1:1.5 (60). Briefly, 5.8 mg cholesterol or 4-cholesten-3-one and 8
mg PC were dissolved in chloroform, and a thin film was prepared; subsequently,
the film was dissolved in 1 ml saline and sonicated (Microson Ultrasonic cell
disruptor with a Misonix 2-mm probe) at 4°C three times for 1 min each time at
maximum output (10). A mixture of cholesterol and PC was also prepared
without sonication and designated an emulsion. To obtain a visual impression,
the morphologies of liposomes and emulsions were studied by performing trans-
mission electron microscopy (TEM) (FEI, The Netherlands) after negative stain-
ing of samples with uranyl acetate (32). The size distributions of liposomes were
determined by measuring the diameters of about 300 liposomes at random using
TEM. To obtain information about lamellation, liposomes in phosphate-buffered
saline (PBS) were mixed with an equal volume of 3% agar and kept at 20°C
overnight. The solidified agar containing vesicles was cut into sections that were
60 nm thick with a cryoultramicrotome (Leica) (23). Sections were stained with
uranyl acetate and then examined by TEM. A liposome prepared from choles-
terol and PC was designated a cholesterol liposome. Similarly, a liposome pre-
pared from 4-cholesten-3-one and PC was designated an analogue liposome.
Liposomes (200 l of a liposomal suspension or emulsion) were injected into
I-hamsters via the intracardiac route as described previously (40). A suboptimal
dose of SAG (sub-SAG) was injected into I-hamsters on days 7, 14, and 21 (day
0 was defined as the date of infection) at a dose of 50 mg/kg (body weight) (21).
Preparation of splenic adherent cells and analysis of their purity. Splenic
adherent cells from hamsters were purified by using an adherence procedure as
described previously (56). To analyze the purity, the phagocytic ability of sheep
red blood cells (SRBC) was studied (56). When preparations were observed
under a microscope, 95% of the adherent cells were phagocytic, as shown by the
presence of intracellular SRBC. As antibodies (Abs) for characterization of
hamster cells are not available, it was not possible to characterize these adherent
cells any further. For convenience, these adherent cells are referred to below as
splenic Ms.
Quantification of membrane cholesterol with an Amplex Red assay kit. The
M membrane was prepared as described previously (27), with some modifica-
tions. Briefly, homogenization of Ms was carried out by repeated freezing and
thawing, and the postnuclear supernatant was harvested by centrifugation at
100,000  g. The resulting precipitate was considered the membrane fraction.
The protein content of the membrane was determined as described previously
(37). The cholesterol content was determined by using an Amplex Red reagent
kit (2), and the results were expressed in M cholesterol/g protein.
T-cell proliferation assay. Single-cell suspensions of splenocytes from different
experimental groups of hamsters were prepared after Ficoll density gradient
centrifugation and then suspended in complete RPMI 1640. Cells were plated in
triplicate at a concentration of 105 cells/well in 96-well plates and allowed to
proliferate for 3 days at 37°C in a 5% CO2 incubator either in the presence or in
the absence of SLA (5 g/ml) (6). For concanavalin A (ConA)-induced prolif-
eration, the mitogen was added at a concentration of 5 g/ml as described
previously (6). At 18 h before harvest, cells were pulsed with 1 Ci [3H]thymi-
dine/well, whose uptake (as an index of proliferation) was measured with a liquid
scintillation counter (Tri-Carb 2100TR; Packard Instruments) as described pre-
viously (6).
Analysis of expression of endogenous leishmanial antigen. Expression of
KMP-11 as an endogenous leishmanial antigen in Ms was checked by staining
with anti-KMP-11 MAb. Ms from normal hamsters, I-hamsters, and cholesterol
liposome-treated I-hamsters (L-I-hamsters) were stained with anti-KMP-11
mouse MAb and then with FITC-conjugated anti-mouse IgG. Stained cells were
then observed with a fluorescence microscope (Leica DMLB).
Generation of anti-KMP-11 T-cell line (TKMP). A KMP-11-expressing mam-
malian expression vector construct (PCMV-LIC KMP-11) was used for immu-
nization (6). A T-cell line was developed by repeated stimulation of primed T
cells with SLA (54). Hamsters were primed with KMP-11 DNA intramuscularly
(with two 150-g booster doses of the plasmid 7 days apart). Spleen cells were
collected 1 month after priming and were stimulated with SLA (5 g/ml) for 2
weeks. The viable cells were purified by using Ficoll-Hypaque, restimulated with
irradiated (3,000 rads; BI 2000 BRIT, Mumbai, India) spleen cells (5  106
cells/ml), and kept for another 2 weeks in the presence of SLA (5 g/ml). The
cycle was repeated once more to enrich antigen-specific T cells. Blasted cells
purified by using Ficoll-Hypaque were designated anti-KMP-11 T-cell line TKMP
and used for subsequent studies.
Analysis of conjugate formation by confocal microscopy. To study conjugate
formation, Ms and TKMP cells were labeled with CTXB-FITC and PKH26,
respectively, as described previously (10). The stained Ms and TKMP cells were
mixed at a ratio of 1:5, resuspended in PBS containing 5% fetal calf serum, and
allowed to form conjugates for 30 min. The cells were then fixed with 1%
paraformaldehyde, mounted with 90% glycerol on a glass slide, and observed
with a confocal microscope (LSM 510; Zeiss). Cells found to be joined in
couplets by phase-contrast microscopy and exhibiting a zone of colocalization as
determined by confocal microscopy were considered to have formed a synapse.
The number of synapse-forming couplets per 100 Ms was expressed as the
percentage of synapse formation.
Intracellular Ca2 mobilization in T cells and assay of IL-2. To determine if
the synapses formed were true synapses, intracellular Ca2 mobilization in TKMP
cells and the resulting interleukin-2 (IL-2) production were monitored using
Ms derived either from I-hamsters (I-Ms) or from L-I-hamsters (L-I-Ms) as
APCs without any exogenous antigen (KMP-11). Briefly, T-cells were resus-
pended in PBS containing 6 M fura-2-acetoxymethyl ester for 60 min at 37°C in
the dark with gentle shaking. The cells were washed with Hanks balanced salt
solution and resuspended in Hanks balanced salt solution containing 0.5 M
EGTA at a concentration of 106 cells/ml. The cell suspension (1 ml) was placed
in a continuously stirred cuvette at room temperature in a fluorimeter (Hitachi
U440). After 1 min of scanning, appropriate APCs were added to the cuvette,
and fluorescence was monitored in real time using excitation wavelengths of 340
nm and 380 nm and an emission wavelength of 510 nm with a bandwidth of 10
nm. The data were expressed as the relative ratio of fluorescence excitation at
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340 to fluorescence excitation at 380 nm (55). Similarly, TKMP cells were mixed
with APCs as described above and incubated at 37°C for 24 h, and the resulting
IL-2 present in the culture supernatant was assayed by determining the [3H]
thymidine uptake using the HT-2 cell line as previously described (10).
Measurement of antileishmanial Ab responses. Serum samples were obtained
from different groups of hamsters (six animals per group) and analyzed to determine
the SLA-specific Ab titer. Ninety-six-well enzyme-linked immunosorbent assay
(ELISA) plates (Nunc) were coated with SLA (2 g/ml) in PBS overnight at 4°C.
The plates were blocked with 5% fetal calf serum in PBS at room temperature for
1 h to prevent nonspecific binding. Sera from different groups of hamsters were
added at various dilutions and incubated for 2 h at room temperature. Sera were
diluted 101, 102, and 103 for determination of IgG1 and 103, 104, and 105
for determination of IgG2. Biotin-conjugated mouse anti-hamster IgG1 and mouse
anti-Armenian and anti-Syrian hamster IgG2 were added and incubated for 1 h at
room temperature; this was followed by 1 h of incubation with the detection reagent
(avidin-conjugated horseradish peroxidase). As a peroxide substrate in citrate buffer
(0.1 M, pH 4.3), ABTS was added along with 0.1% H2O2 to a 96-well plate, and the
absorbance at 405 nm was read with an ELISA plate reader (DTX 800 multimode
detector: Beckman Coulter) (6).
RNA isolation and semiquantitative reverse transcription (RT)-PCR analysis
of cytokines and iNOS. Splenocytes were isolated using the RNeasy minikit
procedure (Qiagen) as described previously (6). The forward and reverse primers
were used to amplify cytokine transcripts. All of these hamster-specific primers
except the inducible NO synthase (iNOS) primer were originally described by
Melby et al. (42). The following forward and reverse primers were used: for
IL-10, forward primer 5ACAATAACTGCACCCACTTC3 and reverse primer
5AGGCTTCTATGCAGTTGATG3 (432-bp product); for IL-4, forward
primer 5CATTGCATYGTTAGCRTCTC3 and reverse primer 5TTCCAGG
AAGTCTTTCAGTG3 (463-bp product); for gamma interferon (IFN-), for-
ward primer 5GGATATCTGGAGGAACTGGC3 and reverse primer 5CGA
CTCCTTTTCCGCTTCCT3 (309-bp product); for tumor necrosis factor alpha
(TNF-	), forward primer 5GACCACAGAAAGCATGATCC3 and reverse
primer 5TGACTCCAAAGTAGACCTGC3 (695-bp product); and for trans-
forming growth factor beta (TGF-
), forward primer 5CCCTGGAYACCAAC
TATTGC3 and reverse primer 5ATGTTGGACARCTGCTCCAC3 (310-bp
product). To obtain specific amplification for iNOS, the following specific prim-
ers were used (6): forward primer 5 GCAGAATGTGACCATCATGG3 and
reverse primer 5CTCGAYCTGGTAGTAGTAGAA3 (198-bp product). For
hypoxanthine-guanine phosphoribosyl transferase (HGPRT) amplification the
following primers were used (42): forward primer 5ATCACATTATGGCCCT
CTGTG3 and reverse primer 5CTGATAAAATCTACAGTYATGG3
(125-bp product). Degenerate bases are indicated above by International Union
of Pure and Applied Chemistry designations (Y C or T; R A or G). Samples
(1 g) of RNA from different experimental groups of hamsters were first utilized
for cDNA synthesis with reverse primers (IDT; Sigma) using mouse Moloney
leukemia virus reverse transcriptase (Invitrogen) at 37°C for 90 min. A common
master mixture containing deoxynucleoside triphosphates (Promega) and Taq
polymerase (Invitrogen), as well as gene-specific primers and 0.25 volume of
cDNA, was used for amplification with an Applied Biosystems thermocycler. The
cycling conditions for genes of interest were 5 min at 95°C, followed by 40 cycles
of denaturation at 95°C for 30 s, annealing at 56°C for 40 s, and extension at 72°C
for 40 s. The identities of the PCR-amplified gene products were verified by
agarose gel electrophoresis. Identical aliquots were processed in parallel without
reverse transcriptase to rule out the presence of residual genomic DNA contam-
ination in PCR amplification preparations. Densitometric analyses were done
using the Quantity One software (Bio-Rad), ethidium bromide staining, and
visualization under a UV transilluminator. For densitometric calculations, the
same band area was used to determine band intensity and normalized for
HGPRT.
Measurement of ROS and NO. To monitor the level of reactive oxygen species
(ROS) (including superoxide, hydrogen peroxide, and other reactive oxygen
intermediates), the cell-permeable, nonpolar, H2O2-sensitive probe 2,7-dichlo-
rofluorescin diacetate was used (43). The extent of H2O2 generation was defined
as the extent of ROS generation for convenience. For each experimental sample,
fluorometric measurements were performed in triplicate, and the results were
expressed asin the mean fluorescence intensity per 106 cells. Nitric oxide (NO)
generation was monitored by using the Griess reaction as described previously
(22), and the results were expressed in M nitrite.
Treatment strategy. Previously, we have shown that in I-hamsters there is
essentially a linear increase in the parasite load in the spleen and liver from 45
days to 120 days postinfection (44). Hamsters infected for 45 days (with promas-
tigotes) and for 60 days (with lesion-derived amastigotes) were used in our study.
The hamsters infected for 45 days were divided into six groups (groups I to VI).
Group I received only saline, whereas groups II to VI received cholesterol
liposomes, analogue liposomes, the emulsion, sub-SAG, and cholesterol lipo-
somes together with sub-SAG (L-I-sub-SAG-hamsters), respectively. All the
animals were sacrificed 30 days after they received the treatment, when splenic
and hepatic parasite burdens were determined.
Survival kinetics. To evaluate long-term therapeutic applicability, 25 I-ham-
sters, 20 L-I-hamsters, and 20 L-I-sub-SAG-hamsters were used to study survival
kinetics as described previously (44).
Statistical analysis. The statistical significance of differences between groups
was determined by the unpaired two-tailed Student t test. Statistical significance
was defined as a P value of 0.05, and results were expressed as averages and
standard deviations of triplicate measurements.
RESULTS
Characterization of liposomes. Liposomes were prepared
from PC either with cholesterol (Fig. 1A) or with its analogue
4-cholesten-3-one (Fig. 1E) and were designated cholesterol
liposomes (Fig. 1B) and analogue liposomes (Fig. 1F), respec-
tively. TEM confirmed that liposomes were indeed formed
upon sonication. The size distributions of liposomes were stud-
ied immediately after preparation. The vesicles were almost
spherical, and the majority of them fell in the size ranges from
60 to 110 nm and from 40 to 115 nm for cholesterol liposomes
(Fig. 1G) and analogue liposomes (Fig. 1H), respectively
(modal sizes, 70 nm and 80 nm, respectively). Ultrathin sec-
tions of liposomes were prepared and viewed by TEM, which
revealed that the cholesterol liposomes were unilamellar ves-
icles (Fig. 1C). Seemingly, there was no liposome formation in
the cholesterol-PC preparation which was not subjected to
sonication, and the resulting suspension was defined as an
emulsion which had a dispersed distribution of lipid without
any defined structure (Fig. 1D).
Delivery of cholesterol liposomes but not analogue lipo-
somes reduced the organ parasite burden in hamsters infected
with promastigotes. There was a significant decrease in the
hepatic parasite burden in response to cholesterol liposome
treatment (group II) compared to I-hamsters (group I) (P 
0.001 for experiments i to iii), whereas analogue liposome
treatment (group III) protected animals on only one occasion
(experiment i; P  0.05) and emulsion treatment (group IV)
provided no protection (Fig. 2). On the other hand, sub-SAG
treatment of I-hamsters (group V) provided protection on two
occasions (P  0.01 and  0.001 for experiments i and iii,
respectively). In the case of L-I-sub-SAG-hamsters (group VI)
there was slight enhancement of the efficacy compared to cho-
lesterol liposome-treated hamsters, but the level of significance
was the same. Cholesterol liposome treatment also resulted in
a significant decrease in the parasite load in the spleen (P 
0.01 for experiments i and iii and P  0.05 for experiment ii).
Neither cholesterol analogue nor emulsion treatment of I-
hamsters offered any protection (Fig. 2). However, the data for
sub-SAG treatment showed wide variation in the results (P 
0.01 for experiments i and iii) (Fig. 2). Clearance of splenic
parasites upon L-I-sub-SAG treatment showed some variation
(P  0.01, P 0.05, and P  0.001 for experiments i, ii, and iii,
respectively) compared to the results for the hepatic parasite
burden (P  0.001, P 0.001, and P  0.001 for experiments
i, ii, and iii, respectively).
Delivery of cholesterol liposomes but not delivery of ana-
logue liposomes reduced the organ parasite burden in ham-
sters infected with amastigotes. Promastigotes are known to be
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at least 1 log less infective than amastigotes (29). Thus, we
studied the effects of cholesterol liposome, analogue liposome,
sub-SAG, and L-I-sub-SAG treatments in hamsters infected
with amastigotes. As expected, the organ parasite load was
significantly greater when animals were infected with amasti-
gotes than when animals were infected with promastigotes.
Hamsters infected for 60 days were divided into five groups
and were treated with saline (group I), cholesterol liposomes
(group II), analogue liposomes (group III), sub-SAG (group
IV), and L-I-sub-SAG (group V). Two independent experi-
ments were performed (experiments i and ii). Cholesterol li-
posome treatment of I-hamsters resulted in a significant re-
duction in the parasite burden both in the liver (P  0.05 and
P  0.001 for experiments i and ii, respectively) and in the
spleen (P  0.01 and P  0.001 for experiments i and ii,
respectively), although the effect was more pronounced in the
spleen. As anticipated, analogue liposome treatment provided
almost no protection. Sub-SAG treatment caused a significant
reduction in the parasite burden in the liver (P  0.05 and P 
0.01 for experiments i and ii, respectively) and in the spleen
(P  0.05 and P  0.01 for experiments i and ii, respectively).
Interestingly, L-I-sub-SAG treatment tended to lower the par-
asite burden further compared to cholesterol liposome treat-
ment alone, but the level of significance remained the same
(Fig. 3).
Cholesterol liposome treatment reversed antileishmanial T-
cell anergy. Patients with kala azar develop immune suppres-
sion (47), and the same is true for experimental infection of
hamsters (16). As a measure of the cell-mediated immune
response, proliferation of splenocytes with leishmanial anti-
gens (SLA) was studied in the hamster model. The results of
this study reinforced similar observations made with spleno-
cytes of I-hamsters which failed to respond to SLA. It was
observed that splenocytes of a cholesterol liposome-treated
group showed a significant antileishmanial T-cell response to
SLA (P  0.05), suggesting that there was an expansion of the
antigen-specific T-cell repertoire due to cholesterol liposome
treatment (Fig. 4), but the splenocytes of analogue liposome-
or lipid emulsion-treated groups failed to respond. Further-
more, splenocytes of hamsters receiving sub-SAG also re-
sponded to SLA (P  0.05), whereas splenocytes of hamsters
receiving cholesterol liposomes and sub-SAG showed vigorous
antileishmanial proliferation (P  0.001). These observations
indicated that for expansion of the T-cell repertoire, choles-
terol needs to be delivered in the form of liposomes and not as
an emulsion. Furthermore, L-I-sub-SAG treatment had addi-
tive effects on the expansion of the antileishmanial T-cell rep-
ertoire (Fig. 4). To determine if there is generalized immune
suppression in I-hamsters, we tested the ability of splenocytes
to respond to ConA. It was observed that the splenocytes of
I-hamsters failed to display a proliferative response to ConA,
but this behavior was reversed upon cholesterol liposome
treatment (P  0.01). There was low but significant prolifera-
tion of splenocytes in groups treated with analogue liposomes
(P 0.01), the emulsion (P 0.001), and sub-SAG (P 0.01).
Interestingly, L-I-sub-SAG-hamsters showed significantly en-
hanced proliferation (P  0.001) of splenocytes with ConA
(Fig. 4B), suggesting that the immune suppression seen in
experimental visceral leishmaniasis is generalized and can be
reversed by cholesterol liposome treatment. Analogue lipo-
FIG. 1. TEM micrographs of liposomes and lipid emulsions and their size distributions. (A and E) Chemical structures of cholesterol (A) and
4-cholest-3-one (E). A mixture of cholesterol and PC at a molar ratio of 1.5:1 was either sonicated to prepare liposomes (cholesterol liposomes)
(B) or not sonicated (emulsion) (D). (C) Section of liposomes showing lamellation. (F) Similarly, 4-cholesten-3-one, the cholesterol analogue, was
mixed with PC at a molar ratio of 1.5:1 and sonicated to prepare analogue liposomes. (F and G) The size distributions of cholesterol liposomes
(G) and analogue liposomes (H) were analyzed by using TEM and were determined at random by measuring the diameters of 300 individual
liposomes. Magnification, 43,500.
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some and emulsion treatments reversed the generalized im-
mune suppression but had no effect on the antigen-specific
suppression. This observation indicated that cholesterol lipo-
some treatment but not analogue liposome treatment can drive
both antigen-specific and nonspecific T cells.
The level of membrane cholesterol decreased due to infec-
tion and was restored by cholesterol liposome treatment. The
status of cholesterol in the M membrane was assessed by
direct chemical measurement using an Amplex Red assay kit
(2). There was a significant decrease in the level of membrane
cholesterol due to infection (P  0.05), and the level was
restored by cholesterol liposome treatment but not by ana-
logue liposome treatment (Fig. 5).
Expression of endogenous leishmanial antigen, formation of
an APC—T-cell conjugate, mobilization of intracellular Ca2,
and production of IL-2. We have shown that L. donovani-
infected human monocytes can act as anti-KMP-11 peptide-
specific cytotoxic T-lymphocyte targets without exogenous
KMP-11 (7). The expression of KMP-11 on splenic I-Ms and
L-I-Ms was therefore studied. The Ms were stained with
anti-KMP-11 Ab, and the binding was monitored by using
FITC-conjugated anti-mouse IgG. The results demonstrate
FIG. 2. Parasite burdens in the spleen and liver of hamsters infected with promastigotes. The groups and their treatments are indicated at the
top and bottom, respectively. Hamsters infected for 45 days (group I) received the following treatments: cholesterol liposomes (group II), analogue
liposomes (group III), emulsion (group IV), sub-SAG (group V), and a combination of cholesterol liposomes and sub-SAG (group VI). SAG was
administered intramuscularly at a dose of 50 mg/kg (body weight) on days 7, 14, and 21. All the hamsters were sacrificed 30 days after liposome
treatment, and the parasite burdens in the spleen and liver were determined. Each data point indicates the parasite burden in a hamster either
in the spleen or in the liver. The results of three representative experiments (experiments i, ii, and iii) are shown.
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that both I-Ms and L-I-Ms show expression of KMP-11
(Fig. 6). It was also observed that the signal for KMP-11 stain-
ing was somewhat weaker in I-Ms than in L-I-Ms. The
ability of I-Ms and L-I-Ms to form synapses with TKMP cells
was also investigated. Optimal synapse formation was observed
at 30 min. The levels of conjugate formation with I-Ms and
L-I-Ms were 2% and 20%, respectively (Fig. 6). To show that
the synapse formed was a true synapse, intracellular Ca2
mobilization in T cells and IL-2 production in TKMP cells were
studied under identical conditions. Increases in both intracel-
lular Ca2 mobilization in T cells and IL-2 production in the
supernatant were observed when TKMP cells were stimulated
with L-I-Ms but not when TKMP cells were stimulated with
I-Ms (Fig. 6). This very clearly indicated that L-I-Ms, but
not I-Ms, can serve as APCs to drive T cells.
Cholesterol liposome treatment increased IFN-, iNOS, and
TNF- levels but decreased IL-4, IL-10, and TGF- levels in
splenocytes. The ability of cytokines and iNOS to undergo
modulation in L-I-hamsters was compared to the ability of
cytokines and iNOS to undergo modulation in I-hamsters by
profiling cytokine gene expression. Representative data for six
independent hamsters in each group are shown in Fig. 7A and
B. The results generated from a densitometry analysis of each
hamster were collectively expressed as means  standard de-
viations for each cytokine, and the statistical significance be-
tween groups was determined (Fig. 7C). Comparative cytokine
analysis showed that the expression of IFN- transcripts, the
expression of TNF-	 transcripts, and the expression of iNOS
transcripts were 2.5, 2.74, and 2.26 times higher, respectively,
in L-I-hamsters than in I-hamsters, whereas the levels of IL-4,
FIG. 3. Parasite burdens in the spleen and liver of hamsters infected with amastigotes. The groups and their treatments are indicated at the
top and bottom, respectively. Hamsters infected for 60 days (group I) received the following treatments: cholesterol liposomes (group II), analogue
liposomes (group III), sub-SAG (group IV), and a combination of cholesterol liposomes and sub-SAG (group V). SAG was administered as
described in the legend to Fig. 2. All the hamsters were sacrificed 30 days after liposome treatment, and the parasite burdens in the spleen and
liver were determined. The results of two representative experiments (experiments i and ii) are shown.
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TGF-
, and IL-10 transcripts were 2.5-, 13-, and 2-fold lower,
respectively (Fig. 7C). Studies of the ratio of IFN- to TGF-

and the ratio of IFN- to IL-10 revealed that the IFN-/TGF-

ratio was 35-fold greater in L-I-hamsters than in I-hamsters
(Fig. 7D). Similarly, the IFN-/IL-10 ratio was 3.65-fold
greater in L-I-hamsters than in I-hamsters (Fig. 7D).
Cholesterol liposome treatment induced generation of ROS
and NO. Generation of nitrite and generation of superoxides
are the main intracellular killing mechanisms for leishmanial
parasites in the Ms (1). A recent ex vivo study showed that
SLA is more efficient in stimulating production of NO (58).
Previously, we found that maximum ROS and NO production
occurred with 5 g/ml of SLA (6). Therefore, splenocytes were
stimulated with SLA, and the resulting ROS production and
NO production were recorded. There was a small but signifi-
cant increase in NO production from the splenocytes of L-I-
hamsters compared to the splenocytes of I-hamsters (P 
0.05), which was accentuated when cholesterol liposome treat-
ment was combined with sub-SAG treatment (P  0.001); this
finding correlated well with the observed protection (Fig. 8).
ROS production in splenocytes was significantly increased
(P  0.001) in L-I-hamsters and was not enhanced when this
treatment was combined with sub-SAG treatment (P  0.01).
However, sub-SAG treatment alone resulted in great variation
in ROS generation. Interestingly, treatment with analogue li-
posomes or the emulsion also induced a low level of ROS
generation (P  0.05) (Fig. 8). When L-I-hamster, analogue
liposome-treated, and emulsion-treated groups were com-
pared, there was no significant difference in NO production,
whereas there was considerably greater ROS generation in
L-I-hamsters than in hamsters in the other two groups (P 
0.01) (Fig. 8).
Cholesterol delivery increased the antileishmanial IgG2/
IgG1 ratio. As no information is available for the helper T-cell
subsets in hamsters, we studied the Ig isotypes in sera of ham-
sters to indirectly assess how T-cell subsets undergo changes
during the active stage of the disease and during protection.
Although there are no distinct classifications of Ig in hamsters,
it is believed that hamster IgG2 corresponds to mouse IgG2a/
IgG2b and hamster IgG1 corresponds to murine IgG1 (16).
There was an increase in the IgG2 level in protected hamsters
compared to the infected group, but there was not much vari-
ation in the IgG1 level in normal, infected, and protected
hamsters. Because the IgG2 titer was much higher than the
IgG1 titer, the sera used for IgG2 determination were diluted
103-, 104-, and 105-fold, whereas the sera used for IgG1
determination were diluted 101-, 102-, and 103-fold (Fig.
9). Even with progressive dilution, the IgG1 titer remained
essentially the same. We therefore determined the median
ratio of IgG2 to IgG1 for the 103 dilution of serum; the
median was determined for only the 103 dilution of serum for
all the groups. The ratios of IgG2 to IgG1 in normal hamsters,
I-hamsters, and L-I-hamsters were 1.44, 1.47, and 4.52 (Fig. 9,
insets), respectively. Thus, L-I-hamsters showed a significant
increase in the IgG2 level, indicating that there was develop-
ment of an effective cellular immune response, which is an
indirect measure of the Th1 type of response.
FIG. 4. Lymphoproliferation of splenocytes in response to SLA at
a concentration of 5 g/ml (A) and to the nonspecific mitogen ConA
(B). The proliferative response was analyzed by using [3H]thymidine
incorporation. The background counts for medium alone varied be-
tween 500 and 1,000 cpm. Two experiments were conducted sepa-
rately, and the data show the results of one representative experiment.
The groups indicated at the top are the groups described in the legend
to Fig. 2.
FIG. 5. Quantification of M membrane cholesterol. Ms (about
90% of the cells were phagocytic with SRBC) from five or six hamsters
were pooled. The status of cholesterol in the M membrane was
assessed by direct chemical measurement using an Amplex Red assay
kit. The bars indicate averages of triplicate measurements, and the
error bars indicate standard deviations.
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Cholesterol liposomes cured infected hamsters in the long
run. The “gold standard” for clinical cure of kala azar is mi-
croscopic determination of the absence of the parasite in
splenic aspirate (11, 63). We performed a microscopic evalu-
ation to detect parasites in stamp smears. For this purpose 25
I-hamsters, 20 L-I-hamsters, and 20 L-I-sub-SAG-hamsters
were used to study the survival kinetics. The I-hamsters had a
maximum life span of 6 months; 80% of these hamsters sur-
FIG. 6. Expression of the endogenous leishmanial antigen KMP-11 in Ms derived from the splenocytes of I-hamsters and L-I-hamsters and
their ability to form synapses with an anti-KMP-11 T-cell line (TKMP cells). Ms were stained with anti-KMP-11 MAb and were probed with
FITC-labeled anti-mouse IgG. Ms from normal hamsters did not show any staining with anti-KMP-11 Ab. To study synapse formation, Ms were
stained with CTXB-FITC, mixed with PKH26-labeled TKMP cells, and kept at 37°C for 30 min. Conjugate formation was analyzed with a confocal
microscope (Zeiss model LSM 510), and the results were expressed as percentages of synapse formation. Cells found in joint couplets by
phase-contrast microscopy and exhibiting a zone of colocalization as determined by confocal microscopy were considered to have formed a synapse.
The number of synapse-forming couplets per 100 APCs is expressed as the percentage of synapse formation. To study the extent of true synapse
formation, fura-2-loaded TKMP cells were mixed with Ms, and fluorescence was monitored in real time to determine the intracellular Ca2
mobilization. In a separate experiment using a similar setup, Ms were mixed with TKMP cells, and the resulting IL-2 production in the supernatant
was monitored for the IL-2-dependent cell line HT-2. Growth of HT-2 cells was monitored by using [3H]thymidine incorporation.
FIG. 7. Semiquantitative RT-PCR cytokine (TGF-
, TNF-	, IL-4, IFN-, and IL-10), iNOS, and HGPRT profiles for the splenocytes of
I-hamsters and L-I-hamsters (n  6). Equivalent amounts of RNA from splenic tissues of two groups of hamsters were used as the input for
RT-PCR analysis, where the HGPRT gene was used as the housekeeping control gene. Expression of each cytokine transcript was expressed as
a ratio of cytokine mRNA to HGPRT mRNA. The values obtained from densitometric analysis of each cytokine were expressed as means 
standard deviations instead of individual values. The ratios of IFN- to IL-10 and IFN- to TGF-
 were analyzed for I-hamsters and L-I-hamsters.
Two experiments were conducted separately, and the data show the results of a representative experiment.
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vived up to 2 months, 60% survived up to 4 months, and 20%
survived beyond 5 months and died by 6 months postinfection.
On the other hand, 92% of L-I-hamsters and 100% L-I-sub-
SAG-hamsters remained alive until the termination of exper-
iment (Fig. 10A). After termination of the experiment (i.e., at
9 months postinfection), seven animals from each group were
investigated at random for parasites in the spleen and liver.
Remarkably, no amastigotes could be detected by microscopy
in impressions of Giemsa-stained tissue stamp smears of trans-
verse sections of the spleen and liver. Experiments performed
at random with three hamsters showed that the organ weights
returned to normal (Fig. 10B), while all three hamsters showed
high titers of antileishmanial IgG2 and, to a lesser extent, of
IgG1 (Fig. 10C and D), suggesting that the hamsters were
indeed infected with L. donovani and the antileishmanial im-
mune repertoire was intact.
DISCUSSION
Our study very clearly showed that a single injection of
cholesterol liposomes into I-hamsters (infected with either
promastigotes or amastigotes) caused a significant reduction in
the parasite burden in the spleen and liver. The therapeutic
effect was further enhanced when cholesterol liposomes was
combined with sub-SAG, indicating that this combination may
be considered for reducing the dose of chemotherapeutic
agents in general. In this investigation cholesterol-rich unila-
mellar liposomes were used because of a number of compelling
attributes: (i) this system is an ideal system for delivering
cholesterol to the host cells because of the concentration (ther-
modynamic) gradient (51); (ii) the half-life of the cholesterol-
rich unilamellar liposomes is longer than that of cholesterol-
poor liposomes in the body fluid (32); (iii) small unilamellar
liposomes that are a defined size (70 to 80 nm) are believed to
be targeted to hepatic cells more efficiently than multilamellar
vesicles (13) and theoretically allow passage through large fen-
estrations, such as those of sinusoidal capillaries (19); and (iv)
while in circulation, liposomes readily absorb a vast collection
FIG. 8. Production of leishmanicidal effector molecules (NO and
ROS) by splenocytes derived from different experimental groups of
hamsters. The splenocytes were stimulated with SLA (5 g/ml) and
assayed for NO as described in Materials and Methods. ROS genera-
tion was measured by 2,7-dichlorodihydrofluorescein diacetate stain-
ing of splenocytes from different experimental groups. Three experi-
ments were conducted separately, and the data show the results of a
representative experiment. The groups indicated at the top are the
groups described in the legend to Fig. 2. MFI, mean fluorescence
intensity.
FIG. 9. Antileishmanial IgG1 and IgG2 Ab titers in different
groups of hamsters (normal hamsters, I-hamsters, and L-I-hamsters).
Sera of individual hamsters were assayed to determine the Ab titer by
ELISA. The insets show the median IgG2/IgG1 ratios at a 103 dilu-
tion of sera between I-hamsters and L-I-hamsters. O.D., optical
density.
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of plasma proteins, some of which may act as opsonins direct-
ing liposomes to cell surface receptors and promoting their
uptake by Ms in the liver and spleen (17), the site of parasite
replication.
The therapeutic effect was cholesterol specific because the
analogue with the 3-
-hydroxyl function, 4-cholesten-3-one,
failed to induce any effect. We used this analogue because the
alignment of cholesterol in the membrane is thought to be
supported by a hydrogen bond between the cholesterol OH
group and the amide bond of sphingolipid (64) and this inter-
action is presumably not present in the case of this analogue
because of the lack of an OH group. The fact that the analogue
liposomes failed to provide any protection, unlike cholesterol
liposomes, may be due to the inability of the analogue to stack
in the membrane. Interestingly, injection of a lipid emulsion
made up of cholesterol and PC at the same proportion as that
in cholesterol liposomes failed to provide any protection, sug-
gesting that the emulsion is either cleared rapidly from the
circulation or is unable to transfer cholesterol to the host cells.
It has been reported that liposomes made up of PC and
stearylamine have no significant therapeutic effect in the L.
donovani-infected mouse model (5), lending credence to the
notion that the cholesterol liposomes have therapeutic ability.
Having established that cholesterol liposomes possess ther-
apeutic potential in experimental leishmaniasis, we tried to
determine the host factors in the protection process. Our study
revealed that protected animals show strong antileishmanial
T-cell proliferation, suggesting that there was expansion of the
antileishmanial T-cell repertoire that was absent in analogue
liposome- or emulsion-treated groups. Curiously, I-hamsters
receiving analogue liposomes and emulsion responded to
ConA but not to leishmanial antigen, whereas I-hamsters re-
ceiving cholesterol liposomes responded to both of these fac-
tors. This showed that cholesterol liposomes but not analogue
liposomes favor expansion of antigen-specific T cells in I-ham-
sters. It was interesting that the polyclonal response to ConA
triggered essentially the same growth response (proliferation)
that leishmanial antigen triggered. This may have been due to
the use of a higher concentration of ConA in our study than in
other studies (46, 49). In the present investigation we used
Ms as a prototype of APCs because no hamster-specific re-
agents are available to generate dendritic cells. Furthermore,
FIG. 10. Long-term survival of I-hamsters, L-I-hamsters, and L-I-sub-SAG-hamsters. (A) Percentages of survival. The asterisks indicate when
hamsters were sacrificed. (B) Organ weight (spleen and liver) for I-hamsters, L-I-hamsters, and L-I-sub-SAG-hamsters (three hamsters were
chosen at random from each group). Three-month-old hamsters were used as the normal group as there was not much variation in organ weight
after this. The organ weights (spleen and liver) were recorded 30 days after the hamsters received either cholesterol liposomes or cholesterol
liposomes and sub-SAG and were compared to the data for the corresponding infected groups. The organ weights (spleen and liver) were also
recorded at the time that the experiment was terminated. Bars a and b indicate organ weights for L-I-hamsters and L-I-sub-SAG-hamsters,
respectively. Since all the I-hamsters were dead by 6 months postinfection, there was no infected control for groups that survived until termination
of the experiment. (C and D) The antileishmanial IgG1 (C) and IgG2 (D) levels were determined at the termination of the experiment and were
compared to the data for age-matched controls. Representative data for three hamsters are shown. The statistical significance for comparisons of
normal and infected groups and of infected and protected groups are indicated. The error bars indicate standard deviations. OD, optical density.
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intravenously injected liposomes target their content only to
the Ms that are in contact with circulating blood (i.e., Kupffer
cells in the liver and several subpopulations of splenic Ms)
(53); fortuitously, these are the target cells where parasites
replicate. This also showed that the cholesterol content of
splenic I-Ms was significantly lower than that of splenic L-I-
M, which was evident from quantitative determination of
membrane cholesterol.
The impact of the decrease in membrane cholesterol on the
T-cell-stimulating ability of I-Ms was also assessed. Previ-
ously, we have shown that L. donovani-infected human mono-
cytes can act as anti-KMP-11 peptide-specific cytotoxic T-lym-
phocyte targets without exogenous KMP-11 (7). The present
study revealed that KMP-11 was expressed in both I-Ms and
L-I-Ms as an endogenous antigen and that the signal was
weaker in the former Ms. We also studied the ability of
I-Ms and L-I-Ms to form synapses with TKMP cells in the
absence of exogenous KMP-11. Their activation was measured
utilizing intracellular Ca2 mobilization and IL-2 production
as a marker of true synapse formation as these two events go
hand in hand (38). There are reports that endogenously de-
rived leishmanial antigens can activate CD4 T cells (30) and
CD8 T cells (31). In one investigation the microtubule orga-
nizing center was used as a marker of T-cell activation (41).
However, we believe that Ca2 mobilization is more sensitive
because it is an upstream event required for microtubule as-
sembly (39). The percentages of synapse formation with I-Ms
and L-I-Ms were 2% and 20%, respectively; in the latter case
both Ca2 mobilization and IL-2 production were noted, sug-
gesting that the synapses were true synapses. There has been a
report that the accessibility of some membrane proteins is
affected depending on a change in the membrane fluidity (45).
The observation described above indicates the importance of
membrane cholesterol for developing antileishmanial immu-
nity and subsequent protection in L. donovani-infected ham-
sters.
The mechanism by which L-I-Ms show enhanced binding
of anti-KMP-11 Ab is not known. However, it is possible that
the accessibility of anti-KMP-11 Abs may be due to the rigidity
of the membrane, as shown by other workers with model mem-
branes (26). An alternative possibility is that because of its
ability to fold and unfold KMP-11 may interact with the mem-
brane lipid (18). There is spectroscopic evidence showing that
variation in the cholesterol concentration in the membrane can
perturb the protein secondary structure; this has been well
studied in photosystem II of chloroplasm (8) and in the cho-
lecystokinin receptor (24).
We have noticed downregulation of the IL-10 mRNA level
in L-I-hamsters compared to I-hamsters. The level of IL-10, a
key M-deactivating Th1-suppressive cytokine, is reported to
increase during an acute phase of visceral leishmaniasis; cure is
associated with a decrease in the level (20). It has also been
suggested that TNF-	 is one of the important agents that
stimulate Ms to produce NO (35). We observed significant
increases in the levels of IFN-, TNF-	, and iNOS transcripts
coupled with generation of ROS and NO in the splenocytes of
L-I-hamsters compared to I-hamsters. However, the picture
was a little different when NO generation and ROS generation
were compared for the L-I-hamster, analogue-treated, and
emulsion-treated groups. It was observed that there was sig-
nificantly greater ROS generation in L-I-hamsters than in the
other two groups. On the other hand, there was not much
difference in NO production among these groups. Thus, it is
reasonable to speculate that in cholesterol liposome-mediated
protection ROS may play a more important role than NO.
IFN- and TNF-	 are often reported to act in concert to
activate iNOS for the production of NO (36). We found sig-
nificant downregulation of TGF-
 in L-I-hamsters compared
to infected controls. TGF-
 has also been recognized as an
important immunoregulator in murine leishmaniasis; it in-
creases the susceptibility to disease (66). TGF-
 suppresses
IFN--induced MHC class II expression by inhibiting class II
transactivator mRNA (34), while cholesterol treatment atten-
uates or suppresses TGF-
 responsiveness in all cell types
studied (12). It has been shown by Anderson et al. (3) that the
therapeutic efficacy of TGF-
 neutralization is potentiated by
simultaneous inhibition of IL-10 (3), indicating the importance
of both of the cytokines in disease progression. We like to
emphasize the possible role of TGF-
 in the outcome of L.
donovani infection in hamsters because the IFN-/TGF-
 ratio
changed dramatically compared to the IFN-/IL-10 ratio upon
cholesterol liposome treatment.
In mice, IL-4 and IFN- are two cytokines that direct Ig class
switching of IgG1 and IgG2a, respectively (62). Although there
is no distinct classification of Igs in hamster, it is believed that
hamster IgG2 corresponds to mouse IgG2a/IgG2b and ham-
ster IgG1 corresponds to murine IgG1 (16). L-I-hamsters ex-
hibit an effective immune response by showing substantially
higher anti-SLA-specific IgG2 titers, which is a measure of the
cell-mediated immune response. There was a significant in-
crease in the IgG2/IgG1 ratio in the protected hamsters com-
pared to the infected group. Therefore, our study was re-
stricted to only a single injection. We used sub-SAG with
cholesterol liposomes, which slightly enhanced the parasite
clearance compared to cholesterol liposome treatment alone
but failed to provide sterile protection at an early time point (1
month after liposome treatment). Therefore, we studied the
long-term survival of the hamsters. From the mortality data it
was clear that a single cholesterol liposome treatment in-
creased the life expectancy of 92% of the hamsters, whereas
combined therapy ensured 100% survival until termination of
the experiments after 9 months. At that time point we deter-
mined the spleen and liver weights and also the parasite bur-
den. Surprisingly, the organ weights were close to normal, and
no parasites could be detected either in L-I-hamsters or in
L-I-sub-SAG-hamsters by the stamp smear method. The pro-
tected hamsters showed the presence of antileishmanial Ab,
indicating that they were indeed exposed to parasites. There
was variation in the number of parasites in the spleens and
livers in infected hamsters, the cause of which is not clear. But
it seems likely that the variation in parasite burden may have
occurred because the animals were not members of a pure
inbred population. Syrian hamsters are believed to have the
limited driving force characteristic of epizootics. To avoid any
controversy concerning polymorphism of MHC molecules, am-
biguous terms like “diversity” and “variation” are used in the
literature. There is no clear-cut convincing data on the extent
of polymorphism at both the class I and class II loci. However,
there is some agreement that MHC class I of Syrian hamsters
is essentially monomorphic (65).
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In conclusion, it appears that the use of cholesterol as an
adjunct might help reduce the doses and thereby the toxicities
of the known antileishmanial drugs. The central conclusion
from this work is that infection led to an increase in membrane
fluidity as a consequence of a decrease in the level of mem-
brane cholesterol and this possibly compromised the APC
function. The cholesterol liposome-driven protective immunity
may be the consequence of the corrected membrane fluidity of
APCs. The resulting expansion of the antileishmanial T-cell
repertoire and generation of host-protective cytokines coupled
with production of oxygen and nitrogen intermediates culmi-
nated in killing of intracellular parasites. This finding does not
exclude the possibility that cholesterol is incorporated into
other host cells, including dendritic cells and T cells, upon
cholesterol liposome treatment. But it is evident that choles-
terol liposome treatment allows recovery of the immune re-
sponse, which eventually wipes out the infection. The mecha-
nism by which intracellular parasites modulate membrane
cholesterol is not known. Obviously, it is necessary to take a
mechanistic look at the event that favored the expansion of
antileishmanial T-cell clones upon cholesterol liposome treat-
ment. This promises to be another area for study of the disease
mechanism and treatment of resistant cases as it focuses on the
host rather than the parasite.
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